10/02/2026
University of Louisville School of Medicine audiology alumnus Jonathon Whitton is helping make medical history.
Whitton was part of the Regeneron team that helped develop Otarmeni — the first FDA-approved gene therapy for genetic hearing loss. Today in Boston, Whitton is celebrating this milestone alongside the scientists, clinicians, patients and families who helped bring this groundbreaking therapy from discovery to the people who need it.
Read more from the U.S. Food and Drug Administration: https://uofl.me/4hqtAwz